FDA authorizes emergency use for Novavax Covid-19 vaccine for ages 12 to 17 - CNBC

Novavax announced on Saturday that its Covid-19 vaccine has been authorized for emergency use by the FDA for adolescents between the ages of 12 and 17.

Biotechnology company Novavax announced on Friday that its Covid-19 vaccine has been authorized for emergency use by the U.S Food and Drug Administration for adolescents between the ages of 12 and 17… [+4854 chars]

full article...